BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12656688)

  • 21. Pathophysiology and current management of pruritus in liver disease.
    Kremer AE; Oude Elferink RP; Beuers U
    Clin Res Hepatol Gastroenterol; 2011 Feb; 35(2):89-97. PubMed ID: 21809485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of ursodeoxycholic acid in liver diseases.
    Kumar D; Tandon RK
    J Gastroenterol Hepatol; 2001 Jan; 16(1):3-14. PubMed ID: 11206313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.
    Trauner M; Graziadei IW
    Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
    Sepúlveda Marín S; Contreras Maragaño V; Vera C
    Medwave; 2016 Jan; 16 Suppl 1():e6361. PubMed ID: 26817509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pruritus in pregnancy.
    Orr B; Usatine RP
    J Fam Pract; 2007 Nov; 56(11):913-6. PubMed ID: 17976338
    [No Abstract]   [Full Text] [Related]  

  • 27. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
    Eisendle K; Müller H; Ortner E; Talasz H; Graziadei I; Vogel W; Höpfl R
    J Gastroenterol Hepatol; 2011 Apr; 26(4):716-21. PubMed ID: 21155876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
    Kremer AE; Oude Elferink RP; Beuers U
    Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
    Tandon P; Rowe BH; Vandermeer B; Bain VG
    Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurov FKh
    Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Pruritus in Primary Biliary Cholangitis: A Narrative Review.
    Trivedi HD; Lizaola B; Tapper EB; Bonder A
    Am J Med; 2017 Jun; 130(6):744.e1-744.e7. PubMed ID: 28238692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding and Treating Pruritus in Primary Biliary Cholangitis.
    Carrion AF; Rosen JD; Levy C
    Clin Liver Dis; 2018 Aug; 22(3):517-532. PubMed ID: 30259850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence.
    Saleh MM; Abdo KR
    J Womens Health (Larchmt); 2007; 16(6):833-41. PubMed ID: 17678454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pruritus in liver disease. Pathogenesis and treatment].
    Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
    Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis and management of pruritus in cholestatic liver disease.
    Imam MH; Gossard AA; Sinakos E; Lindor KD
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1150-8. PubMed ID: 22413872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis.
    Jones EA; Bergasa NV
    Can J Gastroenterol; 2000 Jan; 14(1):33-40. PubMed ID: 10655025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal artificial liver support systems in the management of intractable cholestatic pruritus.
    Fuhrmann V; Drolz A; Trauner M
    Liver Int; 2011 Sep; 31 Suppl 3():31-3. PubMed ID: 21824282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampicin and the relief of pruritus of hepatic cholestatic origin.
    Airede AK; Weerasinghe HD
    Acta Paediatr; 1996 Jul; 85(7):887-8. PubMed ID: 8819563
    [No Abstract]   [Full Text] [Related]  

  • 40. Studying pruritus in the 21st century.
    Bergasa NV
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):249-51. PubMed ID: 15017664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.